Singapore markets open in 4 hours 19 minutes

Straits Times Index
3,293.13
+20.41(+0.62%)
S&P 500
5,071.63
+1.08(+0.02%)
Dow
38,460.92
-42.77(-0.11%)
Nasdaq
15,712.75
+16.11(+0.10%)
Bitcoin USD
64,015.53
-2,274.45(-3.43%)
CMC Crypto 200
1,378.85
-45.25(-3.18%)

Spruce Biosciences, Inc. (SPRB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

0.7018

+0.0006

(+0.09%)

At close: 04:00PM EDT

0.7086

+0.01

(+0.97%)

After hours:

04:19PM EDT

Loading interactive chart…

Business Wire
Spruce Biosciences Announces Upcoming Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting
SOUTH SAN FRANCISCO, Calif., April 22, 2024--Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that a submitted abstract was accepted for poster presentation at the Pediatric Endocrine Society (PES) 2024 Annual Meeting taking place May 2-5, 2024, in Chicago, IL.
Zacks
Spruce Biosciences (SPRB) Upgraded to Buy: Here's What You Should Know
Spruce Biosciences (SPRB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Simply Wall St.
Revenue Downgrade: Here's What Analysts Forecast For Spruce Biosciences, Inc. (NASDAQ:SPRB)
The latest analyst coverage could presage a bad day for Spruce Biosciences, Inc. ( NASDAQ:SPRB ), with the analysts...